Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China flag China · Delayed Price · Currency is CNY
55.72
+0.80 (1.46%)
Apr 29, 2026, 4:00 PM EDT

SHE:301033 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
373.49368.83272.26227.54195.02153.79
Other Revenue
--6.183.330.24-
373.49368.83278.44230.87195.25153.79
Revenue Growth (YoY)
26.63%32.46%20.61%18.24%26.96%24.51%
Cost of Revenue
75.2172.9257.6341.5831.2627.29
Gross Profit
298.28295.91220.81189.29163.99126.5
Selling, General & Admin
143.4139.42114.04116.17105.5773
Research & Development
37.9236.9627.0926.7830.6125.88
Other Operating Expenses
-7.02-7.410.622.12.040.66
Operating Expenses
174.31168.97141.84145.09138.2599.49
Operating Income
123.97126.9478.9744.225.7427.01
Interest Expense
---0.9-2.21-1.78-0.49
Interest & Investment Income
2.632.945.485.459.786.49
Currency Exchange Gain (Loss)
--0.44-0.011.04-0.47
Other Non Operating Income (Expenses)
-2.85-1.21-0.26-0.2-0.13-0.14
EBT Excluding Unusual Items
123.76128.6683.7247.2434.6532.4
Gain (Loss) on Sale of Investments
1.010.190.150.13-0.810.98
Gain (Loss) on Sale of Assets
0.010.010-0.170.01
Asset Writedown
-3.16-2.68-0.48-0.22-1.29-0.07
Other Unusual Items
--9.770.877.2518.28
Pretax Income
121.62126.1793.1648.0239.9651.6
Income Tax Expense
11.9413.0414.37.144.236.92
Earnings From Continuing Operations
109.68113.1378.8540.8835.7344.68
Minority Interest in Earnings
----0.160.03
Net Income
109.68113.1378.8540.8835.8944.71
Net Income to Common
109.68113.1378.8540.8835.8944.71
Net Income Growth
24.54%43.46%92.90%13.89%-19.73%20.95%
Shares Outstanding (Basic)
676666666657
Shares Outstanding (Diluted)
676766666657
Shares Change (YoY)
0.94%1.87%-0.33%-0.80%17.43%14.83%
EPS (Basic)
1.651.711.200.620.540.79
EPS (Diluted)
1.641.691.200.620.540.79
EPS Growth
23.38%40.83%93.55%14.82%-31.65%5.33%
Free Cash Flow
86.63116.0583.2267.6-87.65-86.2
Free Cash Flow Per Share
1.301.731.271.02-1.32-1.52
Dividend Per Share
--0.6000.4000.2000.100
Dividend Growth
--50.00%100.00%100.00%-
Gross Margin
79.86%80.23%79.30%81.99%83.99%82.25%
Operating Margin
33.19%34.42%28.36%19.15%13.18%17.56%
Profit Margin
29.37%30.67%28.32%17.71%18.38%29.08%
Free Cash Flow Margin
23.20%31.46%29.89%29.28%-44.89%-56.05%
EBITDA
151153.62104.2868.1138.9933.18
EBITDA Margin
40.43%41.65%37.45%29.50%19.97%21.57%
D&A For EBITDA
27.0326.6925.3123.9113.256.17
EBIT
123.97126.9478.9744.225.7427.01
EBIT Margin
33.19%34.42%28.36%19.15%13.18%17.56%
Effective Tax Rate
9.82%10.34%15.35%14.88%10.58%13.41%
Revenue as Reported
--278.44230.87195.25153.79
Advertising Expenses
--19.0732.5643.1223.01
Source: S&P Global Market Intelligence. Standard template. Financial Sources.